PolyPid

Recent Finacing

Series E I

Recent Raise

$50M

PolyPid is a clinical-stage biopharmaceutical company that develops and manufactures PLEX polymer-lipid drug-delivery systems for prolonged local release of antimicrobials, including D-PLEX for surgical-site infection prevention and BonyPid coatings.

Founded 2008

HaMerkaz, Israel

51-100

Publicly Traded

polypid.com

Highlights

Focus Areas

Biopharma

Biotechnology

Health Care

Pharmaceutical

Recent Investors

Financials

$17.4M

Valuation as of 01/07/2013

$74.4M

Total Raised

3

Funding rounds

2

Investors

Team

Upgrade to view the team

See the team members at PolyPid.